Send us Fan Mail

The hosts recap a chaotic first week of April 2026 cannabis headlines, clarifying their April Fools clickbait about federal legalization and focusing on real developments: a new CMS/Medicare CBD program tied to the Commonwealth Project and Howard Kessler that offers limited oral-only low-THC/CBD coverage through a small number of approved vendor networks, alongside FDA non-enforcement despite federal-law conflicts; a lawsuit seeking to stop the program had its TRO denied with another hearing slated for late April. They discuss hemp restrictions taking effect March 31 (including Texas), South Carolina indictments over marijuana/THC products, a challenge to Michigan’s new wholesale marijuana tax, and Georgia’s bipartisan medical cannabis expansion removing a 5% THC cap, adding vapes for 21+, and expanding qualifying conditions. The conversation also covers frustrations with Illinois social equity loans and dispensary delays, skepticism about certain licensing lawsuits, Virginia rollout concerns, and ends with a Howard Law Group promotion for cannabis transactions and litigation.

00:00 April Fools Headlines
01:53 Medicare CBD Rollout
04:41 Why Seniors Only
05:58 AI Video Backlash
09:59 Dispensary Money Crunch
11:07 Lawsuit And FDA Memo
14:46 Hemp Kids And YouTube
19:05 Pam Bondi Fired
20:52 Michigan Tax Lawsuit
22:02 Illinois Hemp Politics
25:20 Georgia Medical Expansion
28:17 Alcohol Versus Cannabis
30:09 Brands Closing Down
30:31 Marketing Rules Reality
31:37 Weed Normalization Debate
32:55 Virginia Rollout Critique
36:22 Funding Zoning Barriers
38:28 Social Equity vs MSOs
41:16 Illinois Lawsuit Hot Take
43:35 Delivery IP and Hemp
48:07 Investing Options Basics
53:24 Texas and State Crackdowns
55:05 Illinois Loans Frustration
57:30 Howard Law Group Outro

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

Illinois Social Equity Loan Delays, Hemp/THC Crackdowns, and Shifting Federal-State Cannabis Policy

The episode reviews cannabis legalization news while focusing on Illinois’s stalled social equity loan program: about 160+ applicants sought a $40 million fund, were promised decisions by January then delayed into spring, and the hosts argue the Illinois DCEO’s inaction is pushing operators into defaults, forcing fronted rent and buildout costs, and potentially prompting Court of Claims litigation. They discuss broader regulatory frustration, contrasting state bureaucracy with perceived federal movement, including a planned federal/CMS-style CBD product coverage pilot with strict THC caps that tighten further in November, plus concerns about bans and limits on inhalables/flower and full-spectrum CBD. The hosts anticipate Texas lawsuits over impending hemp/THCA restrictions, note Missouri’s cease-and-desist actions and microbusiness losses, cover South Carolina’s THC beverage bill limits, mention Idaho’s medical marijuana ballot signature progress, and promote ACPrivilege.ai for non-discoverable AI legal queries and Collateral Base consulting.

00:00 Going Live Intro
00:05 Illinois Loan Delays
02:02 Equity Program Breakdown
03:43 Hemp Loopholes Backlash
05:34 Federal CBD Crackdown
07:38 Dispensary Cash Crunch
10:01 Texas Lawsuit Countdown
12:53 Bureaucrats vs Entrepreneurs
15:30 Missouri Hemp Enforcement
18:49 Illinois Politics and Hemp
20:14 White House Policy Meeting
26:13 Science Standards and Consumers
27:53 What Being High Means
28:58 Deportations Over Weed
29:27 South Carolina THC Drinks
31:36 Hemp Loopholes and Factions
34:57 CBD Medicare Subsidy Debate
39:13 Trolls and Cannabis Risks
43:22 Minnesota Policy Stalls
45:20 Medical Program Failures
48:00 Idaho Ballot Push
48:50 AI Privilege Legal Tool
54:10 Collateral Base Closing Ad

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

Tom hosts another episode of Cannabis Legalization News, recapping the week’s major policy and market developments. The show covers the newly introduced bipartisan CLIMB Act (Capital Lending and Investment for Marijuana Businesses Act), which would provide safe harbor for U.S. stock exchanges and market participants to list and trade cannabis-related securities. They discuss reports that “Pot Inc.” is poised to benefit from President Trump’s marijuana reclassification directive, but that DOJ—under Pam Bondi—has no deadline and is still working through a complicated internal process, while rescheduling alone won’t create a full regulatory framework. The episode also reviews CMS/Medicare guidance moving toward coverage of certain hemp-derived full-spectrum CBD edibles with strict limits (under 3 mg THC per serving, later tightening), benefiting companies like Charlotte’s Web. Additional topics include a CRS rescheduling update, state-level restrictions, Virginia adult-use timing, dispensary build-out/financing realities, and cannabis marketing limits.

00:00 Welcome and Week Ahead
02:01 Climb Act Wall Street Access
03:50 Politics Gas and Gripes
05:06 Trump Reclassification Watch
06:55 CMS Hemp CBD Rules
09:35 Charlotte's Web Stock Surge
12:41 CRS Rescheduling Update
16:42 State Markets and Homegrow
20:46 DEA Data Youth Use Down
22:45 State Legislation Virginia Focus
26:40 Ballot Rules Block Legalization
28:13 Verano Loan Breakdown
29:54 Building a Brand Lounge
31:09 Amazon Style Ad Revenue
32:08 Regulatory Steps and Loans
32:44 Wisconsin Hemp Guardrails
33:54 Why Dispensaries Take Years
37:43 Strain Talk Ridgeline Runtz
39:18 AI Tools and Weed Blog
42:08 Interstate Commerce and Branding
45:15 Pricing Menus and Market Fit
46:53 Missouri Expansion and Exit Strategy
48:36 Wrap Up and Legal Sponsor

Support the show

Get our newsletter: https://bit.ly/3VEn9vu